Cargando…
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and morbidity worldwide, with high and growing prevalence. Its underdiagnosis and hence under-treatment is a general feature across all countries. This is particularly true for the mild or early stages of the disease, when...
Autores principales: | Rossi, Andrea, Butorac-Petanjek, Bojana, Chilosi, Marco, Cosío, Borja G, Flezar, Matjaz, Koulouris, Nikolaos, Marin, José, Miculinic, Neven, Polese, Guido, Samaržija, Miroslav, Skrgat, Sabina, Vassilakopoulos, Theodoros, Vukić-Dugac, Andrea, Zakynthinos, Spyridon, Miravitlles, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587130/ https://www.ncbi.nlm.nih.gov/pubmed/28919728 http://dx.doi.org/10.2147/COPD.S132236 |
Ejemplares similares
-
Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
por: Marčetić, Dejan, et al.
Publicado: (2021) -
Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease
por: Hlapčić, Iva, et al.
Publicado: (2019) -
Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation
por: Crkvenac, Maja, et al.
Publicado: (2018) -
Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease
por: Markelić, Ivona, et al.
Publicado: (2022) -
Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia
por: Banić, Marko, et al.
Publicado: (2022)